60 days
Fewer CKD blood-pressure readings above 150 mmHg
In one Vironix RPM analysis, 25–30% of systolic readings initially exceeded 150 mmHg. The reported range declined to 0–15% over 60 days.
Review the 60-day analysisFree practice estimate
Tell us a little about your practice. We'll send an illustrative estimate of the remote patient monitoring and chronic care management revenue your patients could support, and how Vironix would run the program alongside your team.
Estimates are illustrative. Reimbursement depends on eligibility, medical necessity, payer rules, and documentation, and is not guaranteed.
Takes about a minute.
A short, practice-specific summary you can share with your partners and billing team.
A range of patients in your Medicare panel who are commonly eligible for remote patient monitoring and chronic care management.
The CPT codes involved and an illustrative monthly revenue range, using current Medicare national rates.
Who handles enrollment, devices, monitoring, and documentation, so you can see the work your team keeps and the work Vironix takes on.
If you move forward
Responsibilities, contacts, and escalation protocols are agreed with your practice before any patient enrolls.
Your practice confirms clinical appropriateness while Vironix supports population review, outreach, consent, and enrollment.
Patients receive an approved cellular device, education, and support for sending readings securely.
Trained monitoring staff review routine activity, follow up with patients, and route qualifying concerns under your approved protocol.
Time, care activity, and device data are organized into claim-ready reports for your billing team or billing partner.
Published Vironix program results
These observational results describe the populations and periods reported in the linked Vironix analyses. They do not guarantee the same result for every patient or program.
60 days
In one Vironix RPM analysis, 25–30% of systolic readings initially exceeded 150 mmHg. The reported range declined to 0–15% over 60 days.
Review the 60-day analysis150 days
In a program serving patients with CKD, COPD, and diabetes, the share of systolic readings above 150 mmHg reportedly declined from almost 30% to about 5% over 150 days.
Review the 150-day analysisFree, illustrative, and sent to your inbox.